Prevention of osteoporosis in women treated for hereditary breast and ovarian carcinoma
- 1 September 1998
- Vol. 83 (5) , 830-834
- https://doi.org/10.1002/(sici)1097-0142(19980901)83:5<830::aid-cncr2>3.0.co;2-m
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Perspective slow-release sodium fluoride in osteoporosisJournal of Bone and Mineral Research, 1996
- The association of lifetime weight and weight control patterns with bone mineral density in an adult communityBone and Mineral, 1993
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990
- The Future of Hip Fractures in the United StatesPublished by Wolters Kluwer Health ,1990
- Cigarette Smoking, Serum Estrogens, and Bone Loss during Hormone-Replacement Therapy Early after MenopauseNew England Journal of Medicine, 1985
- Cigarette Smoking and Urinary EstrogensNew England Journal of Medicine, 1982
- Bone Morphometry in AlcoholicsPublished by Wolters Kluwer Health ,1982
- Osteopenia in AlcoholismPublished by Wolters Kluwer Health ,1974